| Sara Deffenbaugh, MD | |
|
9411 N Oak Trfy Ste 100, Kansas City, MO 64155-2262 | |
| (816) 436-1800 | |
| (816) 436-4241 |
| Full Name | Sara Deffenbaugh |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 9411 N Oak Trfy Ste 100, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417395963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9408207 (Kansas) | Secondary |
| 207Q00000X | Family Medicine | 2016023343 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Meritas Health Corporation | 6305748153 | 365 |
News Archive
New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.
Scientists at the Gladstone Institutes have discovered that a certain type of DNA damage long thought to be particularly detrimental to brain cells can actually be part of a regular, non-harmful process.
eHealthInsurance.com the leading online source of health insurance for individuals, families, and small businesses, today released an updated list of frequently asked questions (FAQs) in response to the recent extension of the federal COBRA subsidy, along with some additional resources and tools.
Women younger than 55 years represent less than 5 percent of all hospitalized heart disease patients, but because so many heart attacks occur in the United State each year, even this small percentage affects a large number of people.
StockPreacher.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.
Scientists at the Gladstone Institutes have discovered that a certain type of DNA damage long thought to be particularly detrimental to brain cells can actually be part of a regular, non-harmful process.
eHealthInsurance.com the leading online source of health insurance for individuals, families, and small businesses, today released an updated list of frequently asked questions (FAQs) in response to the recent extension of the federal COBRA subsidy, along with some additional resources and tools.
Women younger than 55 years represent less than 5 percent of all hospitalized heart disease patients, but because so many heart attacks occur in the United State each year, even this small percentage affects a large number of people.
StockPreacher.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Entity Name | Gashland Clinic Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962481457 PECOS PAC ID: 8426081613 Enrollment ID: O20050917000236 |
News Archive
New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.
Scientists at the Gladstone Institutes have discovered that a certain type of DNA damage long thought to be particularly detrimental to brain cells can actually be part of a regular, non-harmful process.
eHealthInsurance.com the leading online source of health insurance for individuals, families, and small businesses, today released an updated list of frequently asked questions (FAQs) in response to the recent extension of the federal COBRA subsidy, along with some additional resources and tools.
Women younger than 55 years represent less than 5 percent of all hospitalized heart disease patients, but because so many heart attacks occur in the United State each year, even this small percentage affects a large number of people.
StockPreacher.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sara Deffenbaugh, MD 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116-3254 Ph: (816) 691-5287 | Sara Deffenbaugh, MD 9411 N Oak Trfy Ste 100, Kansas City, MO 64155-2262 Ph: (816) 436-1800 |
News Archive
New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.
Scientists at the Gladstone Institutes have discovered that a certain type of DNA damage long thought to be particularly detrimental to brain cells can actually be part of a regular, non-harmful process.
eHealthInsurance.com the leading online source of health insurance for individuals, families, and small businesses, today released an updated list of frequently asked questions (FAQs) in response to the recent extension of the federal COBRA subsidy, along with some additional resources and tools.
Women younger than 55 years represent less than 5 percent of all hospitalized heart disease patients, but because so many heart attacks occur in the United State each year, even this small percentage affects a large number of people.
StockPreacher.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 1 days ago
George Wesley Roodhouse, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 6675 Holmes Rd Ste 360, Kansas City, MO 64131 Phone: 816-276-7650 Fax: 816-276-7992 | |
Sabrina Diane Knoch, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Nw 68th St, Kansas City, MO 64118 Phone: 816-420-6300 | |
Dr. Avery Thomas Abernathy, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6450 N Chatham Ave, Kansas City, MO 64151 Phone: 816-741-5542 Fax: 816-746-4262 | |
Rance Mcclain, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Carondelet Dr, Suite #220, Kansas City, MO 64114 Phone: 816-941-1600 Fax: 816-941-1699 | |
Dr. Valerie Lynn Duff, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6675 Holmes Rd Suite 360, Kansas City, MO 64131 Phone: 816-276-7600 | |
Dr. Heather Renee Bollinger, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5501 Nw 62nd Ter Ste 100, Kansas City, MO 64151 Phone: 816-842-4440 Fax: 816-842-1974 | |
Christopher Paul Trimble, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9784 N Ash Ave, Kansas City, MO 64157 Phone: 816-781-4244 Fax: 816-781-3542 |